Characterization of Influenza Vaccine Immunogenicity Using Influenza Antigen Microarrays

Background Existing methods to measure influenza vaccine immunogenicity prohibit detailed analysis of epitope determinants recognized by immunoglobulins. The development of highly multiplex proteomics platforms capable of capturing a high level of antibody binding information will enable researchers and clinicians to generate rapid and meaningful readouts of influenza-specific antibody reactivity. Methods We developed influenza hemagglutinin (HA) whole-protein and peptide microarrays and validated that the arrays allow detection of specific antibody reactivity across a broad dynamic range using commercially available antibodies targeted to linear and conformational HA epitopes. We derived serum from blood draws taken from 76 young and elderly subjects immediately before and 28±7 days post-vaccination with the 2008/2009 trivalent influenza vaccine and determined the antibody reactivity of these sera to influenza array antigens. Results Using linear regression and correcting for multiple hypothesis testing by the Benjamini and Hochberg method of permutations over 1000 resamplings, we identified antibody reactivity to influenza whole-protein and peptide array features that correlated significantly with age, H1N1, and B-strain post-vaccine titer as assessed through a standard microneutralization assay (p<0.05, q <0.2). Notably, we identified several peptide epitopes that were inversely correlated with regard to age and seasonal H1N1 and B-strain neutralization titer (p<0.05, q <0.2), implicating reactivity to these epitopes in age-related defects in response to H1N1 influenza. We also employed multivariate linear regression with cross-validation to build models based on age and pre-vaccine peptide reactivity that predicted vaccine-induced neutralization of seasonal H1N1 and H3N2 influenza strains with a high level of accuracy (84.7% and 74.0%, respectively). Conclusion Our methods provide powerful tools for rapid and accurate measurement of broad antibody-based immune responses to influenza, and may be useful in measuring response to other vaccines and infectious agents.

[1]  Eva K. Lee,et al.  Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans , 2009, Nature Immunology.

[2]  Phillip Stafford,et al.  A general method for characterization of humoral immunity induced by a vaccine or infection. , 2010, Vaccine.

[3]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[4]  Trevor Hastie,et al.  Regularization Paths for Generalized Linear Models via Coordinate Descent. , 2010, Journal of statistical software.

[5]  Y. Guan,et al.  Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells , 2008, PloS one.

[6]  Harry B. Greenberg,et al.  Influence of Prior Influenza Vaccination on Antibody and B-Cell Responses , 2008, PloS one.

[7]  E. Moxon,et al.  New Decade of Vaccines 1 The next decade of vaccines: societal and scientifi c challenges , 2011 .

[8]  Kathy Hancock.  Influenza A Virus , 2020, Definitions.

[9]  Atul J Butte,et al.  Protein Microarrays Discover Angiotensinogen and PRKRIP1 as Novel Targets for Autoantibodies in Chronic Renal Disease , 2010, Molecular & Cellular Proteomics.

[10]  A. Fauci,et al.  Induction of unnatural immunity: prospects for a broadly protective universal influenza vaccine , 2010, Nature Medicine.

[11]  G. Lüchters,et al.  Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination? , 2004, Virus research.

[12]  G. Dinant,et al.  The Efficacy of Influenza Vaccination in Elderly Individuals: A Randomized Double-blind Placebo-Controlled Trial , 1994 .

[13]  James E. Crowe,et al.  Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus , 2010, Science.

[14]  R. Webster,et al.  The Influenza Virus Enigma , 2009, Cell.

[15]  Lynne Pearce.  A prescription. , 2003, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[16]  G. Paranhos-Baccala,et al.  Identification of a Highly Conserved H1 Subtype-Specific Epitope with Diagnostic Potential in the Hemagglutinin Protein of Influenza A Virus , 2011, PloS one.

[17]  Lysine methylation of the NF-κB subunit RelA by SETD6 couples activity of the histone methyltransferase GLP at chromatin to tonic repression of NF-κB signaling , 2011, Nature Immunology.

[18]  R. Tibshirani,et al.  Regression shrinkage and selection via the lasso: a retrospective , 2011 .

[19]  A. Jungbauer,et al.  The FLAG peptide, a versatile fusion tag for the purification of recombinant proteins. , 2001, Journal of biochemical and biophysical methods.

[20]  W. Blackwelder,et al.  Antibody and Th1-type cell-mediated immune responses in elderly and young adults immunized with the standard or a high dose influenza vaccine. , 2011, Vaccine.

[21]  M. Jaimes,et al.  Baseline Levels of Influenza-Specific CD4 Memory T-Cells Affect T-Cell Responses to Influenza Vaccines , 2008, PloS one.

[22]  Charles R. Mace,et al.  Label-free, arrayed sensing of immune response to influenza antigens. , 2011, Talanta.

[23]  Hongjie Dai,et al.  Plasmonic substrates for multiplexed protein microarrays with femtomolar sensitivity and broad dynamic range. , 2011, Nature communications.

[24]  M. Schutkowski,et al.  High-density peptide microarrays for reliable identification of phosphorylation sites and upstream kinases. , 2009, Methods in molecular biology.

[25]  Uenza Manu.  WHO Manual on Animal Influenza Diagnosis and Surveillance , 2002 .

[26]  Bastian R. Angermann,et al.  Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses , 2008, The Journal of experimental medicine.

[27]  Li Li,et al.  Identifying compartment-specific non-HLA targets after renal transplantation by integrating transcriptome and “antibodyome” measures , 2009, Proceedings of the National Academy of Sciences.

[28]  Cécile Viboud,et al.  Antibody response to influenza vaccination in the elderly: a quantitative review. , 2006, Vaccine.

[29]  J. Skehel,et al.  Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. , 2000, Annual review of biochemistry.

[30]  P. Brown,et al.  Autoantigen microarrays for multiplex characterization of autoantibody responses , 2002, Nature Medicine.

[31]  Emanuel F Petricoin,et al.  Protein microarrays: meeting analytical challenges for clinical applications. , 2003, Cancer cell.

[32]  Ian A. Wilson,et al.  Structure and Receptor Specificity of the Hemagglutinin from an H5N1 Influenza Virus , 2006, Science.

[33]  N. Cox,et al.  Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2006, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[34]  E. Moxon,et al.  The next decade of vaccines: societal and scientific challenges , 2011, The Lancet.

[35]  R. Liskamp,et al.  Peptides and Proteins as a Continuing Exciting Source of Inspiration for Peptidomimetics , 2011, Chembiochem : a European journal of chemical biology.

[36]  Eva K. Lee,et al.  Systems Biology of Seasonal Influenza Vaccination in Humans , 2011, Nature Immunology.

[37]  D. Knook,et al.  Quality and quantity of the humoral immune response in healthy elderly and young subjects after annually repeated influenza vaccination. , 1999, The Journal of infectious diseases.

[38]  Mark M Davis,et al.  A prescription for human immunology. , 2008, Immunity.

[39]  M. Wigler,et al.  Purification of a RAS-responsive adenylyl cyclase complex from Saccharomyces cerevisiae by use of an epitope addition method , 1988, Molecular and cellular biology.

[40]  Lawrence Steinman,et al.  Microarray Profiling of Antibody Responses against Simian-Human Immunodeficiency Virus: Postchallenge Convergence of Reactivities Independent of Host Histocompatibility Type and Vaccine Regimen , 2003, Journal of Virology.

[41]  J. Skehel,et al.  A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins , 2011, Science.

[42]  Peter Bühlmann.  Regression shrinkage and selection via the Lasso: a retrospective (Robert Tibshirani): Comments on the presentation , 2011 .

[43]  Francisco A. Chaves,et al.  The memory phase of the CD4 T‐cell response to influenza virus infection maintains its diverse antigen specificity , 2011, Immunology.

[44]  Y. Keynan,et al.  Evaluation of influenza-specific humoral response by microbead array analysis. , 2011, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

[45]  R. Tibshirani.  Regression Shrinkage and Selection via the Lasso , 1996 .

[46]  B. L. Beattie,et al.  Antibody response to whole-virus and split-virus influenza vaccines in successful ageing. , 1993, Vaccine.

[47]  Junbao Yang,et al.  Peptide-MHC Cellular Microarray with Innovative Data Analysis System for Simultaneously Detecting Multiple CD4 T-Cell Responses , 2010, PloS one.

[48]  S. Cusack,et al.  Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid , 1988, Nature.

[49]  A. Butte,et al.  Multiplexed protein array platforms for analysis of autoimmune diseases. , 2006, Annual review of immunology.

[50]  J. McElhaney,et al.  Influenza vaccine responses in older adults , 2011, Ageing Research Reviews.

[51]  R. Couch.  Seasonal inactivated influenza virus vaccines. , 2008, Vaccine.

[52]  Arthur E. Hoerl,et al.  Ridge Regression: Biased Estimation for Nonorthogonal Problems , 2000, Technometrics.

[53]  C. Liu,et al.  “On silico” peptide microarrays for high-resolution mapping of antibody epitopes and diverse protein-protein interactions , 2011, Nature Medicine.

[54]  K. Subbarao,et al.  Antigenic Fingerprinting of H5N1 Avian Influenza Using Convalescent Sera and Monoclonal Antibodies Reveals Potential Vaccine and Diagnostic Targets , 2009, PLoS medicine.

[55]  Thomas R. Riley,et al.  A Randomized Double-blind Placebo-controlled Trial , 2004 .

[56]  C. Liu,et al.  Epigenome Microarray Platform for Proteome-Wide Dissection of Chromatin-Signaling Networks , 2009, PloS one.

[57]  Mark M. Davis,et al.  Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies. , 2011, The Journal of clinical investigation.

[58]  Bonnie Bruce,et al.  Antigen microarray profiling of autoantibodies in rheumatoid arthritis. , 2005, Arthritis and rheumatism.

[59]  J. Crowe,et al.  A Broadly Neutralizing Human Monoclonal Antibody That Recognizes a Conserved, Novel Epitope on the Globular Head of the Influenza H1N1 Virus Hemagglutinin , 2011, Journal of Virology.